InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Huber Martin H. Jr., Director. Officer active across 3 companies, notably Syndax Pharmaceuticals Inc. Cumulatively, 11 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €40k. History available since 2 February 2022. The latest transaction was filed on 4 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Huber Martin H. Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
24,000 shares0Common StockSEC:0001193125-26-041344:0
9,573 sharesCommon StockSEC:0001104659-26-001376:0
6,670 shares0Common StockSEC:0001104659-25-090026:0
5,000 shares@ US$8.99100.0% of flowCommon StockSEC:0000950170-25-074297:0
Canonical exit: 17 Aug 2025 (T+90)
25,000 shares0Common StockSEC:0000950170-25-016351:0
11,062 shares0Common StockSEC:0001104659-25-004593:0
166,750 shares0Common StockSEC:0001104659-24-099855:0
17,000 shares0Common StockSEC:0001562180-24-001220:0
14,467 shares0Common StockSEC:0001104659-23-070362:0
16,000 shares0Common StockSEC:0001562180-23-000946:0
16,000 shares0Common StockSEC:0001562180-22-001069:0
11 of 11 declarations
About Huber Martin H. Jr.
Martin H. Huber Jr. serves as a Director at Syndax Pharmaceuticals Inc. In this role, he participates in the company's strategic decisions and governance. Huber brings expertise in biopharmaceuticals and research, which is crucial for Syndax's innovation. His commitment to excellence and strategic vision are assets to the board.
